A Glutathione IV drip is a wellness treatment where glutathione, a naturally occurring antioxidant, is administered directly into the bloodstream through an intravenous infusion
Twelve peptides that had been placed on the FDAs Category 2 restricted compounding list in 2023 are coming off that list effective April 23, 2026
One failed our tests for providing only 81% of its listed amount of glutathione
Mechanism of Action Acetyl Group Protection : The attached acetyl group acts as a molecular shield, preventing digestive enzymes from breaking down glutathione prematurely in the stomach and intestines, which allows the intact molecule to reach target tissues like the liver, lungs, and brain
These analytical methods are essential for quality control in research settings where peptide purity directly impacts experimental outcomes
GHK-Cu timelines differ based on administration route